Local delivery of low-dose anti–CTLA-4 to the melanoma lymphatic basin leads to systemic Treg reduction and effector T cell activation

Role of Naturally Arising Regulatory T Cells in Hematopoietic Cell Transplantation - Biology of Blood and Marrow Transplantation

A guide to cancer immunotherapy: from T cell basic science to clinical practice

Understanding and treating the inflammatory adverse events of cancer immunotherapy. - Abstract - Europe PMC

Cancers, Free Full-Text

Recent advances in light-triggered cancer immunotherapy - Journal of Materials Chemistry B (RSC Publishing) DOI:10.1039/D3TB02842A

Local delivery of low-dose anti–CTLA-4 to the melanoma lymphatic basin leads to systemic Treg reduction and effector T cell activation

Full article: Advances in the development of tumor-infiltrating lymphocyte therapy for advanced melanoma

Targeting CTLA‐4 in cancer: Is it the ideal companion for PD‐1 blockade immunotherapy combinations? - De Silva - 2021 - International Journal of Cancer - Wiley Online Library

New insights on the mechanism of action of anti-CTLA-4 immune checkpoint blockade

Systemic therapy for hepatocellular carcinoma: outlook